Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
EBITDA Growth
-22.72%
TTM · Period ending:
BIO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.72%period ending
Latest reported-22.72%period ending
BIO TTM EBITDA YoY % (31.37% → -22.72%)
Year-over-year change
High-resolution chart · PNG
BIO ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 32.6114% | |
| 40.5884% | |
| 58.8331% | |
| 75.5183% | |
| 69.332% | |
| 68.0701% | |
| 45.9347% | |
| 37.1324% | |
| 25.0645% | |
| 12.5766% | |
| 12.527% | |
| -0.8081% | |
| -9.3236% | |
| -12.522% | |
| -22.7045% | |
| -16.5261% | |
| -6.0137% | |
| -1.3913% | |
| 6.3943% | |
| 6.4632% | |
| 5.8182% | |
| 4.927% | |
| 5.2336% | |
| 23.5033% | |
| 37.8446% | |
| 61.1765% | |
| 98.8848% | |
| 49.3377% | |
| 28.7097% | |
| 42.2594% | |
| -5.614% | |
| 9.4203% | |
| 7.6389% | |
| -34.3407% | |
| -16.6667% | |
| -26.5957% | |
| -20.442% | |
| 0.5525% | |
| -1.4409% | |
| 23.2787% | |
| 22.7119% | |
| 21.8855% | |
| -54.6997% | |
| 154.5617% | |
| 290.3226% | |
| 15.5642% | |
| 284.9246% | |
| -219.7002% | |
| -139.2405% | |
| -12.585% | |
| 21.3415% | |
| 34.5821% | |
| 47.3881% | |
| 52.3316% | |
| 38.9831% | |
| 32.9502% | |
| 31.3725% |